Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Drugs & Aging|December 31, 1997
Clinical pharmacokinetics of nifedipine. Implications for the care of the elderlyH L Elliott, P A MeredithJournal of Cardiovascular Pharmacology|January 1, 1994
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationP A Meredith, H L ElliottJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertensionH L Elliott, P A MeredithClinical Pharmacology and Therapeutics|June 1, 1992
An additive or synergistic drug interaction: application of concentration-effect modelingP A Meredith, H L ElliottBritish Journal of Clinical Practice. Supplement|May 1, 1994
Therapeutic coverage: reducing the risks of partial complianceP A Meredith, H L ElliottJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1994
Methodological considerations in calculation of the trough: peak ratioH L Elliott, P A MeredithPostgraduate Medical Journal|January 1, 1991
The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipineH L Elliott, P A MeredithClinical Cardiology|September 1, 1994
Amlodipine--does the effect-time profile directly reflect the concentration-time profile throughout a 24-hour period?P A Meredith, H L ElliottJournal of Cardiovascular Pharmacology|January 1, 1993
Amlodipine; clinical relevance of a unique pharmacokinetic profileP A Meredith, H L ElliottJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1994
Antihypertensive treatment and trough: peak ratio: general considerationsP A Meredith, H L ElliottPageof 27